Marker of cardiovascular disease also associated with bone problems in patients with HIV

Michael Carter
Published: 18 July 2011

An important marker of sub-clinical cardiovascular risk is associated with reduced bone mineral density in the hips of HIV-positive patients, according to Italian research presented to the Sixth International AIDS Society conference (IAS 2011) in Rome.

The investigators found that calcification – or hardening – of the coronary artery was associated with low bone density in the femoral hip.

“The cross correlation between bone demineralisation and subclinical atherosclerosis is of interest in light of the accelerated bone demineralisation and high fracture rate noted in HIV-infected subjects along with increased cardiovascular risk,” Dr Antonio Bellasi of the Metabolic Clinic, University of Modena and Reggio Emilia, told delegates.

Cardiovascular disease and changes in bone metabolism are current hot topics in HIV care.

Research conducted in HIV-negative patients has found that individuals with reduced bone mineral density are also more likely to have hardening of the coronary artery. This association appears to be of clinical significance. Post-menopausal women with osteoporosis are known to have an increased risk of a cardiovascular event. Moreover, both hardening of the arteries and osteoporosis have a similar pathology, and they are also share risk factors – for example low levels of vitamin D, a highly prevalent condition in HIV-positive people.

However, little is known about the association between calcification of the coronary artery and bone mineral density in HIV-positive patients.

The Italian investigators therefore undertook a study involving 812 patients who received care between 2006 and 2010.

They hypothesised that there would be a relationship between cardiovascular and bone complications in these patients.

None of the patients had a history of cardiovascular disease. After monitoring, the patients were divided into two groups dependent on their coronary artery calcification score (above or below 100, the higher score indicating more hardening of the artery).

Bone mineral density was also measured in the lower spine and femoral neck of the hip. An individual was defined as having low bone mineral density if this was below the 25th percentile.

Hardening of the coronary artery was associated with a number of traditional risk factors including older age, male sex, poorer kidney function, diabetes, high blood pressure, a high ten-year Framingham risk score, and high body mass index.

There was a higher prevalence of low bone mineral density in the hip among patients with a coronary artery calcification score above 100 than in patients with a score below 100 (23 vs 15%).

However, reduced bone mineral in the lower spine was comparable between patients with higher and lower calcification scores (16 vs 15%).

A series of statistical analyses were then performed to see which factors were associated with hardening of the coronary artery and reduced bone density in the hip.

The first model found a near-significant association between age and sex (odds ratio [OR] = 1.73; 95% CI, 0.88-3.38, p = 0.10).

A second model added risk factors for cardiovascular disease such as a high body mass index, diabetes and a high Framingham score, and the result found an increased risk that fell just short of statistical significance (OR = 2.01; 95% CI, 0.97-4.19, p = 0.06).

Adding HIV-related factors, including CD4 cell count, viral load and treatment with tenofovir (Viread, also in the combination pills Truvada and Atripla), made the association significant (OR = 2.33; 95% CI, 1.11-4.86, p = 0.02).

The final model,  including kidney function, vitamin D levels, and thyroid function had little impact on this finding (OR = 2.33; 95% CI, 1.09-4.99, p = 0.02).

A 'bootstrap' analysis that compensated for the low number of recorded events confirmed the robustness of the investigators’ findings. It also underlined the significance of traditional risk factors such as age, kidney function and diabetes to coronary calcification and reduced bone mineral density in the femoral neck of the hip.

The investigators were unable to explain why hardening of the coronary artery was associated with reduced bone density in the hip, but not in the spine.

However, they emphasised that lifestyle changes such as regular exercise, a good diet, and stopping smoking could reduce both cardiovascular and bone problems in patients with HIV.

Dr Bellasi concluded, “future studies should test the hypothesis that therapies that attenuate cardiovascular risk in HIV may also favourably impact bone mineral density in these patients.”


Bellasi A et al. Coronary artery calcification is associated with femoral but not with lumbar spine mineral density. Sixth International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, Rome, abstract MOAB0102, 2011.

View the abstract on the conference website

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.